Literature DB >> 9543317

Acute cytomegalovirus infection and IgM anti-GM2 antibody.

N Yuki1, Y Tagawa.   

Abstract

Guillain-Barré syndrome (GBS) sometimes is preceded by cytomegalovirus (CMV) infection. Irie et al. (J. Neuroimmunol. 1996;68:19-26) reported that three patients with GBS subsequent to CMV infection had IgM and IgG anti-GM2 antibodies. In our larger study, the IgMs from the CMV-associated GBS patients showed significantly higher anti-GM2 antibody titers than anti-GM3, anti-GD1a, anti-GD1b, anti-GD2, anti-GD3, anti-GT1b, anti-GQ1b, and anti-SGPG antibody titers. None of the anti-glycosphingolipid antibody titers differed significantly from the others in the IgGs from the CMV-associated GBS patients. However, IgM anti-GM2 antibody frequently was present in GBS patients who were not preceded by CMV infection and non-GBS patients with acute CMV infection. Our results did not support the conclusion of Irie et al. that anti-GM2 antibodies were closely associated with acute CMV infection in GBS, but acute CMV infection, with and without GBS, was associated with IgM anti-GM2 antibody.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543317     DOI: 10.1016/s0022-510x(97)00174-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Didier Taravel; Valérie Sivadon-Tardy; David Orlikowski; Flore Rozenberg; Tarek Sharshar; Jean Claude Raphaël; Jean Louis Gaillard
Journal:  J Neurol       Date:  2011-04-24       Impact factor: 4.849

3.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

Review 4.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

5.  Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.

Authors:  S Usuki; K Taguchi; S A Thompson; P B Chapman; R K Yu
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

6.  Twelfth cranial nerve involvement in Guillian Barre syndrome.

Authors:  Subrat Kumar Nanda; Sita Jayalakshmi; Devashish Ruikar; Mohandas Surath
Journal:  J Neurosci Rural Pract       Date:  2013-07

7.  Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome.

Authors:  Jong Kuk Kim; Yoo Hwan Kim; Byeol A Yoon; Joong Yang Cho; Sun Young Oh; Ha Young Shin; Ji Soo Kim; Kee Hong Park; Sun Young Kim; Bum Chun Suh; Hung Youl Seok; Jin Hyuk Yoo; Jong Seok Bae
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

8.  A Guillain-Barré syndrome variant with prominent facial diplegia.

Authors:  Keiichiro Susuki; Michiaki Koga; Koichi Hirata; Emiko Isogai; Nobuhiro Yuki
Journal:  J Neurol       Date:  2009-07-25       Impact factor: 6.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.